
Avicanna Inc. (OTCQX:AVCNF) (TSX:AVCN) (FSE:0NN) will be expanding its RHO Phyto formulary in Canada with Cannabigerol (“CBG”) formulations into medical and adult-use channels across Canada.
Avicanna expands its RHO Phyto brand to include several CBG formulations which will be made available across various medical cannabis channels including Medical Cannabis by Shoppers and adult-use channels beginning with its two listings on the Ontario Cannabis Store in Q3 2022.